Illumina
Overview

Date:
8th July 2025, Tuesday

Time:
10:00 am - 11:00 am (Cape Town)
12:00 pm - 01:00 pm (Dubai)
01:30 pm – 02:30 pm (Delhi)
03:00 pm - 04:00 pm (Bangkok)
04:00 pm - 05:00 pm (Singapore)
05:00 pm - 06:00 pm (Seoul / Tokyo)
06:00 pm - 07:00 pm (Melbourne)

Register Now
We understand that our webinar timing may not suit your busy schedule. Please feel free to register to get the on-demand recording link once it is ready.

Implementing WHO recommendations for NGS in Drug-Resistant Tuberculosis (DR-TB) can seem like a complex journey. Looking for clarity and a clear path forward?

This webinar is part of a six-part webinar series which provides a practical roadmap and real-world guidance by showcasing the implementation journeys of pioneering national TB programs integrating targeted NGS into their TB testing algorithms. In this webinar, Eswatini - in the integration phase, will share their experience of pioneering their national TB program.

This focused 30-minute webinar delivers specific stories and lessons learned aligned with these implementation stages, offering a comprehensive understanding of the process and the tangible impact of NGS on DR-TB control.

Gain practical insights to accelerate your End TB goals by learning directly from the pioneering experts leading this transformative change. Ready to translate WHO recommendations into actionable strategies? Register now for the whole six-part webinar series.

In this series, you will discover:

  • The key drivers and infrastructure considerations for adopting tNGS in diverse national settings.
  • Understanding of national models for NGS-enhanced TB testing algorithms.
  • Real-world impact and best practices for successful tNGS implementation.

Speakers:

Dr Debrah Vambe
Global TB Program Instructor
Baylor College of Medicine, Eswatini

Debrah has 17 years of professional medical and public health experience. She is currently at Baylor College of Medicine as the Global TB Program Instructor, Regional Study manager for TB GAPS Project in Eswatini, Lesotho, Malawi, Uganda, and Tanzania as well as the Program Director for the D43 paediatric research capacity-building project entitled Growing HIV/TB Research Knowledge for Growing Healthy Kids in Eswatini.

She was previously the National Programmatic Management of Drug Resistance TB (PMDT) Technical Advisor for almost 10 years-coordinating and ensuring integration between National TB and HIV Programs in implementation of DR-TB and TB/HIV initiatives. In her current leadership role, she focuses on strategic planning, programming, coordination, health care provider capacity building, health systems strengthening, operational research, new innovations, monitoring and evaluation of diagnostics, supply chain and treatment cascades, advocacy, and resource mobilization towards improved treatment outcomes. In her previous role, she led development and revisions of key strategic documents (strategic plans, guidelines, TB/HIV training materials, job aids, information, education, and communication (IEC) materials, recording, and reporting tools.

Dr Tendai Nkomo
TB and Research Technical Advisor
Ministry of Health, National TB Control Program, Eswatini

Dr Tendai Nkomo is a dedicated Medical Doctor and Public Health Specialist with over a decade of experience in the health sector, working across various levels of healthcare delivery, including international technical assistance. With seven years of focused expertise in combating infectious diseases such as TB, HIV, and DR-TB, along with their co-morbidities, Dr Nkomo brings robust program management skills and a strong background in health system strengthening to deliver impactful and sustainable healthcare solutions.

Mangaliso Bhekumusa Ziyane
Senior TB Sequencing Technologist
Ministry of Health Eswatini’s National TB Reference Laboratory

Mangaliso Bhekumusa Ziyane is an experienced Laboratory Technologist and Acting Laboratory Manager with a focus on improving TB diagnostics in Eswatini. He has demonstrated strong expertise in quality management systems, particularly with the successful ISO15189 re-accreditation of the National TB Reference Laboratory and his role as the SADCAS nominated representative. In a leadership capacity, he oversees the national TB diagnostic network and has successfully organized key capacity-building initiatives in the country. Mr. Ziyane has been central to the implementation of next-generation sequencing (NGS) for TB diagnostics and surveillance in Eswatini. He currently holds the position of Senior TB Sequencing Technologist and has been involved in the integration of NGS into the national diagnostic algorithm and the facilitation of a molecular surveillance system.
Register below to join us at the webinar.
Company Legal
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.